IN2014MU00495A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00495A
IN2014MU00495A IN495MU2014A IN2014MU00495A IN 2014MU00495 A IN2014MU00495 A IN 2014MU00495A IN 495MU2014 A IN495MU2014 A IN 495MU2014A IN 2014MU00495 A IN2014MU00495 A IN 2014MU00495A
Authority
IN
India
Prior art keywords
pharmaceutical compositions
abstract
cancer
preparing
treatment
Prior art date
Application number
Other languages
English (en)
Inventor
Geena Malhotra
Preeti Raut
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to IN495MU2014 priority Critical patent/IN2014MU00495A/en
Priority to PCT/GB2015/050384 priority patent/WO2015121649A1/en
Priority to ZA2015/00995A priority patent/ZA201500995B/en
Publication of IN2014MU00495A publication Critical patent/IN2014MU00495A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN495MU2014 2014-02-12 2015-02-12 IN2014MU00495A (enExample)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IN495MU2014 IN2014MU00495A (enExample) 2014-02-12 2015-02-12
PCT/GB2015/050384 WO2015121649A1 (en) 2014-02-12 2015-02-12 Pharmaceutical composition comprising vemurafenib
ZA2015/00995A ZA201500995B (en) 2014-02-12 2015-02-12 Low dose pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN495MU2014 IN2014MU00495A (enExample) 2014-02-12 2015-02-12

Publications (1)

Publication Number Publication Date
IN2014MU00495A true IN2014MU00495A (enExample) 2015-09-25

Family

ID=52544516

Family Applications (1)

Application Number Title Priority Date Filing Date
IN495MU2014 IN2014MU00495A (enExample) 2014-02-12 2015-02-12

Country Status (3)

Country Link
IN (1) IN2014MU00495A (enExample)
WO (1) WO2015121649A1 (enExample)
ZA (1) ZA201500995B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11040027B2 (en) 2017-01-17 2021-06-22 Heparegenix Gmbh Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
CN110831582B (zh) * 2017-07-05 2023-08-11 诺华股份有限公司 药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2738573C (en) * 2009-04-03 2013-02-19 F. Hoffmann-La Roche Ag Compositions of propane-1 sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide and uses thereof
US20130172375A1 (en) * 2011-12-13 2013-07-04 Hoffmann-La Roche Inc. Pharmaceutical composition

Also Published As

Publication number Publication date
ZA201500995B (en) 2015-12-23
WO2015121649A1 (en) 2015-08-20

Similar Documents

Publication Publication Date Title
ZA202004557B (en) Modulatory polynucleotides
PH12018501151A1 (en) Tank-binding kinase inhibitor compounds
PH12016501898B1 (en) Quinoxaline derivatives useful as fgfr kinase modulators
ZA201605715B (en) Cyclopropylamines as lsd1 inhibitors
MX2016015862A (es) Compuestos inhibidores de la cinasa de union a tank.
PH12016501601A1 (en) Cyclopropylamines as lsd1 inhibitors
PH12016500330B1 (en) Certain chemical entities, compositions, and methods
TW201613860A (en) Cyclopropylamines as LSD1 inhibitors
TW201613886A (en) 3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
MX2022001310A (es) Compuesto de fenil-2-hidroxi-acetilamino-2-metil-fenilo.
UA117182C2 (uk) Нові композиції, їх використання і способи одержання
IN2014MU00303A (enExample)
HK1254231A1 (zh) 米托-和厚朴酚化合物及其合成方法和用途
PH12017500853B1 (en) Cd44v6-derived cyclic peptides for treating cancers and angionesesis related diseases
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
IN2014CH00840A (enExample)
IN2014MU00916A (enExample)
GEP201706795B (en) Hexahydrofuropyrroles as pde1 inhibitors
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
EA201691620A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
MY182434A (en) Certain chemical entities, compositions, and methods